Results 1 to 10 of about 2,288,987 (292)

Acknowledgment to the Reviewers of Antibodies in 2022

Antibodies, 2023
High-quality academic publishing is built on rigorous peer review [...]
Antibodies Editorial Office
doaj   +1 more source

Acknowledgment to Reviewers of Antibodies in 2021

Antibodies, 2022
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Antibodies Editorial Office
doaj   +1 more source

Acknowledgment to Reviewers of Antibodies in 2020

Antibodies, 2021
Peer review is the driving force of journal development, and reviewers are gatekeepers who ensure that Antibodies maintains its standards for the high quality of its published papers [...]
Antibodies Editorial Office
doaj   +1 more source

Acknowledgement to Reviewers of Antibodies in 2019

Antibodies, 2020
The editorial team greatly appreciates the reviewers who have dedicated their considerable time andexpertise to the journal’s rigorous editorial process over the past 12 months[...]
Antibodies Editorial Office
doaj   +1 more source

Animal Models of IgE Anaphylaxis

Biology, 2023
Allergies and atopy have emerged as significant public health concerns, with a progressively increasing incidence over the last two decades. Anaphylaxis is the most severe form of allergic reactions, characterized by a rapid onset and potentially fatal ...
Aurélie Gouel-Chéron, Alice Dejoux, Emma Lamanna, Pierre Bruhns   +3 more
doaj   +1 more source

Isolation of a human SARS-CoV-2 neutralizing antibody from a synthetic phage library and its conversion to fluorescent biosensors

Scientific Reports, 2022
Since late 2019, the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resultant spread of COVID-19 have given rise to a worldwide health crisis that is posing great challenges to public health and clinical treatment, in ...
Haimei Li, Bo Zhu, Baowei Li, Limei Chen, Xuerao Ning, Hang Dong, Jingru Liang, Xueying Yang, Jinhua Dong, Hiroshi Ueda   +9 more
doaj   +1 more source

Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells

Frontiers in Immunology, 2016
Several technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems.
Dubravka Drabek, Rick Janssens, Ernie de Boer, Rik Rademaker, Johannes Kloess, John Skehel, Frank Grosveld, Frank Grosveld   +7 more
doaj   +1 more source

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model

Frontiers in Oncology, 2022
DNA-encoded delivery and in vivo expression of antibody therapeutics presents an innovative alternative to conventional protein production and administration, including for cancer treatment.
Kevin Hollevoet, Kevin Hollevoet, Debby Thomas, Debby Thomas, Griet Compernolle, Griet Compernolle, Giles Vermeire, Elien De Smidt, Elien De Smidt, Stéphanie De Vleeschauwer, Trevor R. F. Smith, Paul D. Fisher, Maarten Dewilde, Maarten Dewilde, Nick Geukens, Paul Declerck, Paul Declerck   +16 more
doaj   +1 more source

Acknowledgement to Reviewers of Antibodies in 2016

Antibodies, 2017
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016.[...]
Antibodies Editorial Office
doaj   +1 more source

Extreme Point Sort Transformation Combined With a Long Short-Term Memory Network Algorithm for the Raman-Based Identification of Therapeutic Monoclonal Antibodies

Frontiers in Chemistry, 2022
Therapeutic monoclonal antibodies (mAbs) are a new generation of protein-based medicines that are usually expensive and thus represent a target for counterfeiters.
Jin Ling, Luxia Zheng, Mingming Xu, Gang Chen, Xiao Wang, Danzhuo Mao, Hong Shao   +6 more
doaj   +1 more source